Biotech Sector Remains Undervalued - Oppenheimer
Go back to Biotech Sector Remains Undervalued - Oppenheimer| iShares Nasdaq Biotechnology Index Fund (NASDAQ: IBB) | Delayed: 168.92 +2.99 (1.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $165.93 | 52 Week High | $343.87 | |||
| Open | $166.73 | 52 Week Low | $240.03 | |||
| Day High | $169.81 | P/E | N/A | |||
| Day Low | $166.10 | EPS | $0.00 | |||
| Volume | 550,138 | |||||
| SPDR S&P BIOTECH ETF (NYSE: XBI) | Delayed: 131.17 +2.32 (1.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $128.85 | 52 Week High | $73.80 | |||
| Open | $129.14 | 52 Week Low | $44.16 | |||
| Day High | $132.13 | P/E | N/A | |||
| Day Low | $128.45 | EPS | $0.00 | |||
| Volume | 4,966,088 | |||||
